Abstract
A Japanese female patient with angioimmunoblastic T cell lymphoma underwent allogeneic bone marrow transplantation (BMT) from her brother. Cyclosporine at a dose of 3 mg/kg was started by continuous infusion over 24 h on day −1 of BMT. Within a couple of minutes after the infusion was begun, she developed diffuse pruritic erythema on her whole body and tachycardia. The infusion was immediately stopped and corticosteroid was given, resulting in disappearance of the erythema gradually. She was then switched to intravenous tacrolimus. However, she suffered urticalial erythema again. Since polyoxyethylated castor oil, a solubilizer used in the injective formulation of both cyclosporine and tacrolimus, is considered to be responsible for the reaction, she was given oral capsules of cyclosporine (Sandimmun) in which polyoxyethylated castor oil was not contained. No further anaphylactic reaction was observed. The BM cells were successfully engrafted without causing severe GVHD. She was discharged on cyclosporine capsules without any further adverse effects. Anaphylaxis to intravenous cyclosporine and tacrolimus is a very rare but a serious complication. Our present case indicates that oral capsule of Sandimmun is a safe alternative to prevent GVHD in such a case of anaphylactic reaction against intravenous formulation. Bone Marrow Transplantation (2001) 28, 421–423.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ringden O . Cyclosporine in allogeneic bone marrow transplantation Transplantation 1986 42: 445–452
Kahan BD, Wideman CA, Flechner S et al. Anaphylactic reaction to intravenous cyclosporin Lancet 1984 1: 52
Friedman LS, Dienstag JL, Nelson PW et al . Anaphylactic reaction and cardiopulmonary arrest following intravenous cyclosporine Am J Med 1985 78: 343–345
Rowinsky EK, Eisenhauer EA, Chaudhry V et al. Clinical toxicities encountered with paclitaxel (TAXOL) Semin Oncol 1993 20: (Suppl. 3) 1–15
Mounier P, Laroche D, Divanon F et al. Anaphylactoid reactions after intravenous infusion of a cremophor-containing solution of multivitamins Therapie 1995 50: 571–573
Bullen AW, Miller JP, Cunliffe WJ et al. Skin reactions caused by vitamin K in patients with liver disease Br J Dermatol 1978 98: 561–565
Pratschke J, Neuhaus R, Tullius SG et al. Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation Transplantation 1997 64: 938–940
van Hooff JP, Bessems P, Beuman GH et al. The absence of an allergic reaction to cyclosporine capsules in a patient allergic to standard oral and intravenous solution of cyclosporine Transplant Proc 1988 20: (Suppl. 2) 640
Cooney GF, Alpern JB, Narins BE et al. Tolerance of cyclosporine oral capsules in a patient hypersensitive to standard oral and intravenous solutions of the drug Transplantation 1990 49: 823–824
Rakhmanina N, Barnes C, Dowing P et al. Anaphylactoid reaction to intravenous cyclosporine in a child J Aller Clin Immunol 1997 99: S433
Volcheck GW, van Dellen RG . Anaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine: case report and review Ann Aller Asthma Immunol 1998 80: 159–163
Kuiper RAJ, Malingre MM, Beijnen JH et al. Cyclosporine-induced anaphylaxis Ann Pharmacother 2000 34: 858–861
Ptachcinski RJ, Gray J, Venkataramanan R et al. Anaphylactic reaction to intravenous cyclosporine Lancet 1985 1: 636–637
Chapuis B, Helg C, Jeannet M et al. Anaphylactic reaction to intravenous cyclosporine New Engl J Med 1985 312: 1259
Habboush HW, Hann IM . Anaphylactic reaction to cyclosporin in a bone marrow transplant recipient Br J Haematol 1986 62: 195–199
Howrie DL, Ptachcinski RJ, Griffith BP et al. Anaphylactoid reactions associated with parenteral cyclosporine use: possible role of cremophor EL Drug Intell Clin Pharm 1985 19: 425–427
Leunissen KM, Waterval PWG, van Hooff JP . Anaphylactic reaction to intravenous cyclosporine Lancet 1985 1: 636 (Abstr.)
Magalini SC, Nanni G, Agnes S et al. Anaphylactic reaction to first exposure to cyclosporine Transplantation 1986 42: 443–444 (Abstr.)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takamatsu, Y., Ishizu, M., Ichinose, I. et al. Intravenous cyclosporine and tacrolimus caused anaphylaxis but oral cyclosporine capsules were tolerated in an allogeneic bone marrow transplant recipient. Bone Marrow Transplant 28, 421–423 (2001). https://doi.org/10.1038/sj.bmt.1703161
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703161